Ontex Reports H1 Results: Strategic Moves Amid Revenue Challenges
Ontex has recently shared its results for the first half of 2025, indicating a revenue decrease of 4%. This drop can be primarily attributed to reduced demand for baby care products in Europe. The company continues to prioritize significant investments and key transformation milestones despite these challenges.
Revenue and Margin Overview
In the financial review, Ontex reported a revenue of €880 million, reflecting a like-for-like decrease of 4.0%. This decline was driven by a 3.0% drop in volumes, largely in line with the dip in demand across major markets. Baby care products experienced the most significant decline, exacerbated by customer destocking tactics.
The adjusted EBITDA for the period was reported at €86 million, down from €110 million the previous year. This decrease corresponds with an EBITDA margin contraction of 2.2 percentage points to 9.8%. Such changes reflect the challenges of lower sales prices and reduced volume absorption amid rising operational costs.
Market Dynamics and Strategic Developments
CEO Gustavo Calvo Paz remarked on the discouraging results but underscored their commitment to the strategic journey. Ontex has displayed robust performances in its North American segment, indicating that scaling operations remain a focus for future growth. The portfolio reshaping has progressed well, underlined by a strong innovation pipeline that is expected to yield results moving forward.
In significant business movements, Ontex divested its Brazilian subsidiary, garnering net cash proceeds of €99 million. Furthermore, a binding agreement to sell its Turkish operations was made, anticipated to close in the latter part of the year. Additionally, Ontex issued a €400 million high-yield bond set to mature in April 2030, replacing earlier bonds that were fully repaid.
Outlook for 2025
Looking ahead, Ontex foresees a recovery in the second half of the year with expected revenue stabilization despite ongoing soft consumer demand. The anticipated growth will be predominantly driven by new contracts in Europe and North America, coupled with the resolution of temporary supply chain disruptions experienced earlier in the year.
For the remainder of 2025, Ontex has adjusted its full-year guidance, now expecting low single-digit revenue contraction, and adjusted EBITDA to fall within the €200 million to €210 million range. Free cash flow projections have also been updated to approximate zero due to the previous outflows.
Company Commitment to Operational Efficiency
Ontex continues to implement a comprehensive cost transformation program aimed at achieving savings and improving operational efficiencies. Over the last half-year, this program has already yielded a notable €34 million in savings.
Moreover, as Ontex aligns itself towards becoming a more agile and resilient player in the industry, the company remains focused on innovation and enhancing product quality in response to evolving market demands.
Frequently Asked Questions
What led to Ontex's revenue decline in H1 2025?
The revenue decline was primarily driven by reduced demand in baby care products, particularly in Europe, coupled with customer destocking.
What is Ontex's adjusted EBITDA for the first half of 2025?
Ontex reported an adjusted EBITDA of €86 million for H1 2025, a decrease from €110 million in H1 2024.
What strategic actions has Ontex taken recently?
Ontex has successfully divested its Brazilian operations and is working on selling its Turkish business. Additionally, it issued a new high-yield bond to strengthen its financial position.
What is the outlook for Ontex for the rest of 2025?
Ontex anticipates a revenue recovery in the second half of 2025, with an adjusted EBITDA expected in the range of €200 million to €210 million.
How is Ontex addressing current operational challenges?
Ontex is focusing on a cost transformation program to enhance operational efficiency and address rising costs while continuing to invest in innovation.
